TrialNature communications2025

Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: A phase 2 randomized clinical trial.

Jeffrey Khong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.